N
NorthSea Therapeutics
Pan-European biotech company with the aim to develop novel and innovative therapeutic strategies for NASH and other metabolic, inflammatory and fibrotic diseases
About NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company focused on developing innovative therapies for Non-Alcoholic SteatoHepatitis (NASH) and other metabolic, inflammatory, and fibrotic diseases. The company operates primarily in the US, Western Europe, and Japan, targeting a market with an estimated 15-30 million patients affected by NASH. NorthSea's lead program, icosabutate, is a first-in-class Structurally Engineered Fatty Acid (SEFA) currently in late-stage clinical development. The company's business model revolves around the research, development, and commercialization of these novel therapeutics. Revenue is generated through partnerships, licensing agreements, and eventual product sales upon regulatory approval. NorthSea Therapeutics aims to address the unmet medical needs in the NASH treatment landscape, offering a promising alternative to the limited options currently available.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Dec 2021 | $80M | $320M | BioGeneration Ventures · venBio Partners · Novo Seeds · New Science Ventures | ↗ |
| SERIES BOther financing | Jan 2020 | $40M | $158M | Forbion Capital Partners · Novo Seeds · venBio Partners · BioGeneration Ventures | — |
Growth signals
Latest recorded traffic for NorthSea Therapeutics is 590 monthly website visits, down 19.2% over the last three months. NorthSea Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Orbit HealthHarnessing sensors and AI, enables effective early intervention and personalized care for chronic diseases |
Berlin, Germany | Operational | 11 | $1.5M | — |
DycareAI-powered telerehabilitation for musculoskeletal and neurological conditions |
Barcelona, Spain | Operational | |||
Immersive RehabVirtual reality platform for digital neurorehabilitation therapeutics |
London, United Kingdom | Operational | |||
Mindable HealthDigital therapeutics for anxiety |
Berlin, Germany | Operational | |||
Bold HealthDigital therapeutic platform for people with long term conditions |
Miami Beach, United States | Operational | |||
Heranova LifesciencesA Boston-based biotech company solely focused on developing integrated care solutions for women's health issues |
Burlington, United States | Operational | |||
VodorasloYour solution to better air quality |
Sofia, Bulgaria | Operational | |||
Pandora BiosciencesOperates as a neuroscience company |
Cape Town, South Africa | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
NorthSea Therapeutics in the Amsterdam ecosystem
The NorthSea Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Forbion Capital Partners
BioGeneration Ventures
New Science Ventures
Novo Holdings
venBio Partners
Novo Seeds
Sofinnova Investments
Series B and later2 investors entered at this stage
Ysios Capital
Hercules Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NorthSea Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NorthSea Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










